Ces Urol 2023, 27(1):9-16 | DOI: 10.48095/cccu2023002

The WHO Classification of Urinary and Male Genital Tumours 2022: news in the urinary tract neoplasms classification

Tomáš Pitra1, Adriena Bartoš Veselá1, Josef Skopal2, Milan Hora1, Ondřej Hes2, 3, Ondřej Fiala4, Kristýna Pivovarčíková2, 3
1 Urologická klinika, Lékařská fakulta Plzeň, Univerzita Karlova a Fakultní nemocnice Plzeň
2 Šiklův ústav patologie, Lékařská fakulta Plzeň, Univerzita Karlova a Fakultní nemocnice Plzeň
3 Bioptická laboratoř, s. r. o., Plzeň
4 Onkologická a radioterapeutická klinika, Lékařská fakulta Plzeň, Univerzita Karlova a Fakultní nemocnice Plzeň a Biomedicínské centrum, Lékařská fakulta Plzeň, Univerzita Karlova †zesnulý

Pitra T, Bartoš Veselá A, Skopal J, Hora M, Hes O, Fiala O, Pivovarčíková K. The WHO Classification of Urinary and Male Genital Tumours 2022: news in the urinary tract neoplasms classification. The classification of urinary tract neoplasms (so-called blue book) only slightly modifies the last WHO version from 2016. The major change is the modification of the arrangement of the chapters and only minor changes occurred in the nomenclature. The aim of this review is to outline and comment on the changes in the new edition of the WHO classification 2022 of the urinary tract.

Keywords: Classification, urinary tract, urothelial carcinoma, WHO.

Received: February 5, 2023; Revised: March 1, 2023; Accepted: March 1, 2023; Prepublished online: March 2, 2023; Published: March 28, 2023 


References

  1. Tsuzuki T, Compérat E, Netto G, et al. Tumours of the urinary tract. In: WHO Classification of Tumours Editorial Board. Urinary and male genital tumours. Lyon (France): International Agency for Research on Cancer WHO classification of tumours series, 5th ed.; vol. 8; 2022.
  2. Kamoun A, de Reyniès A, Allory Y, et al. A Consensus Molecular Classification of Muscle‑invasive Bladder Cancer. Eur Urol. 2020; 77(4): 420-33. Go to original source... Go to PubMed...
  3. Rosenthal D, Wojcik E, Kurtycz D. The Paris system for reporting urinary cytology. Switzerland: Springer; 2016. Go to original source...
  4. Wojcik EM, Kurtycz DFI, Rosenthal DL. We'll always have Paris The Paris System for Reporting Urinary Cytology 2022. J Am Soc Cytopathol. 2022; 11(2): 62-6. Go to original source... Go to PubMed...
  5. Pitra T, Dikanová M, Hora M, et al. Porovnání výsledků invazivních vyšetření a močové cytologie: Zkušenosti jednoho urologického centra po prvním roce užívání Pařížské klasifikace pro hodnocení močových cytologií. Ces Urol. 2018; 22(4): 275-84. Go to original source...
  6. Amin MB, Comperat E, Epstein JI, et al. The Genitourinary Pathology Society Update on Classification and Grading of Flat and Papillary Urothelial Neoplasia With New Reporting Recommendations and Approach to Lesions With Mixed and Early Patterns of Neoplasia. Adv Anat Pathol. 2021; 28(4): 179-95. Go to original source... Go to PubMed...
  7. Compérat E, Amin MB, Epstein JI, et al. The Genitourinary Pathology Society Update on Classification of Variant Histologies, T1 Substaging, Molecular Taxonomy, and Immunotherapy and PD‑L1 Testing Implications of Urothelial Cancers. Adv Anat Pathol. 2021; 28(4): 196-208. Go to original source... Go to PubMed...
  8. Gutierrez CM, Alemozaffar M, Osunkoya AO. Invasive high‑grade urothelial carcinoma of the bladder, renal pelvis, ureter, and prostatic urethra arising in a background of urothelial carcinoma with an inverted growth pattern: a contemporary clinicopathological analysis of 91 cases. Hum Pathol. 2019; 92: 18-24. Go to original source... Go to PubMed...
  9. Amin MB, Smith SC, Reuter VE, et al. Update for the practicing pathologist: The International Consultation On Urologic Disease‑European association of urology consultation on bladder cancer. Mod Pathol. 2015; 28(5): 612-30. Go to original source... Go to PubMed...
  10. McKenney JK. Precursor lesions of the urinary bladder. Histopathology. 2019; 74(1): 68-76. Go to original source... Go to PubMed...
  11. McKenney JK. Urothelial carcinoma in situ: diagnostic update. Pathology. 2021; 53(1): 86-95. Go to original source... Go to PubMed...
  12. Parwani AV, Levi AW, Epstein JI, Ali SZ. Urinary bladder biopsy with denuded mucosa: denuding cystitis‑cytopathologic correlates. Diagn Cytopathol. 2004; 30(5): 297-300. Go to original source... Go to PubMed...
  13. Sheldon CA, Clayman RV, Gonzalez R, Williams RD, Fraley EE. Malignant urachal lesions. J Urol. 1984; 131(1): 1-8. Go to original source... Go to PubMed...
  14. Brierley JD, Gospodarowicz MK, Wittekind C. TNM Classification of malignant tumours, 8th edition. Wiley‑Blackwell; 2016: 272.
  15. Idrees MT, Alexander RE, Kum JB, Cheng L. The spectrum of histopathologic findings in vesical diverticulum: implications for pathogenesis and staging. Hum Pathol. 2013; 44(7): 1223-32. Go to original source... Go to PubMed...
  16. Lloyd R, Osamura R, Kloppel G, Rosai J. WHO Classification of Tumours of Endocrine Organs (4th Edition). Lyon (France): International Agency for Research on Cancer (IARC); 2017.
  17. Acosta AM, Demicco EG, Dal Cin P. Pseudosarcomatous myofibroblastic proliferations of the urinary bladder are neoplasms characterized by recurrent FN1-ALK fusions. Mod Pathol. 2021; 34(2): 469-77. Go to original source... Go to PubMed...
  18. Babjuk M, Burger M, Compérat EM, et al. European Association of Urology Guidelines on Non‑muscle‑invasive Bladder Cancer (TaT1 and Carcinoma In Situ) - 2019 Update. Eur Urol. 2019; 76(5): 639-57. Go to original source... Go to PubMed...





Web časopisu Česká urologie je určen pouze pro lékaře a odborníky
z oblasti medicíny nebo farmacie.



Beru na vědomí, že informace zveřejněné na těchto stránkách
nejsou určeny pro laickou veřejnost.



Odejít Vstoupit